Improving adherence rates to a cocooning program: a pilot experience in Italy

Hum Vaccin Immunother. 2013 May;9(5):1142-5. doi: 10.4161/hv.23795. Epub 2013 Jan 31.

Abstract

Cocoon is defined as a strategy to reduce the risk for transmission of pertussis to newborn infants by vaccinating household members including parents and siblings. Programmatic challenges make implementation of cocooning program complex. At the local health care unit "ASL Napoli 1 Centro," a one-year pilot project to evaluate the newborn contacts adherence to a cocoon strategy was started on May, 1st 2011. Healthcare providers (HCPs) offered for free a dTpa booster dose to newborns parents (mothers were immunized after delivery) and household contacts. Until June 30th, overall only 7 dTpa booster doses out of 261 newborns (2.6%) were administered for cocooning. Then, an improvement in communication strategy to the families was introduced by preparing specific information leaflets, increasing the HCPs devoted to the cocoon, and focusing the interaction with families during the visiting time at the maternity ward. Overall, 601 out of 762 (78,8%) contacted new mothers received dTpa booster. Cocoon high acceptance rates could be reached providing that proper communication tools and enough skilled HCPs were engaged in the interaction with the families. This report is, to our knowledge, the first to document successful implementation of pertussis cocooning in an Italian setting.

Keywords: cocoon; newborns; pertussis; prevention; transmission.

MeSH terms

  • Adult
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / administration & dosage*
  • Fathers
  • Female
  • Health Education / methods
  • Humans
  • Immunization, Secondary*
  • Infant
  • Infant, Newborn
  • Infant, Newborn, Diseases / prevention & control*
  • Italy / epidemiology
  • Male
  • Medication Adherence / statistics & numerical data*
  • Mothers
  • Patient Acceptance of Health Care
  • Siblings
  • Whooping Cough / prevention & control*
  • Whooping Cough / transmission*

Substances

  • Diphtheria-Tetanus-acellular Pertussis Vaccines